Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis

References

• Siegel RL, Miller KD, Jemal A, Cancer statistics, 2018. CA Cancer J Clin. 2018;68(7):30.
   Google Scholar
• El–Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576.
   PubMed Web of Science ®Google Scholar
• El-Shemy HA, Mama-s A, Nassr-Allah A, et al. Antitumor properties and modulation of antioxidant enzymes activity by aloe vera leaf active principles isolated via supercritical carbon dioxide extraction. Curr Med Chem. 2010;17(2):129–138.
   PubMed Web of Science ®Google Scholar
• Sun R, Zhai R, Ma C, et al. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway. Cancer Med. 2020;9(3):1141–1151.
   PubMed Web of Science ®Google Scholar
• Davis CD, and Ross SA. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev. 2010;66(8) ;477–482.
   Web of Science ®Google Scholar
• Gao SM, Yang JJ, Chen CQ, et al. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res. 2012;31(1):27.
   PubMed Web of Science ®Google Scholar
• Zhang K, Fu G, Pan G, et al. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis. Cell Death Dis. 2018;9(10):1035.
   PubMed Web of Science ®Google Scholar
• Paul P, Chakraborty A, Sarkar D, et al. Interplay between miRNAs and human diseases. J Cell Physiol. 2018;233(3):2007–2018.
   PubMed Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769–773.
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Y, Jiang B,. et al. Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p. Cancer Cell Int.(2020)20:49.
   Google Scholar
• Bergmann L, Miething C, Maurer U, et al. High levels of Wilms‘ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood. 1997;90(3):1217.
   PubMed Web of Science ®Google Scholar
• Glienke W, Maute L, Koehl U, et al. Effective treatment of leukemic cell lines with wt1 siRNA. Leukemia. 2007;21(10):2164–2170.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215.
   PubMed Web of Science ®Google Scholar
• Dame C, Kirschner KM, Bartz KV, et al. Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene. Blood. 2006;107(11):4282.
   PubMed Web of Science ®Google Scholar
• Cai L, Qin X, Xu Z, et al. Comparison of cytotoxicity evaluation of anticancer drugs between real-time cell analysis and CCK-8 method. ACS Omega. 2019;4(7):12036–12042.
   PubMed Web of Science ®Google Scholar
• Pan Y, Ye C, Tian Q, et al. miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade. Oncol Lett. 2018;15:4337–4343.
   PubMed Web of Science ®Google Scholar
• Louca M, Stylianou A, Minia A, et al. Ras suppressor-1 (RSU-1) promotes cell invasion in aggressive glioma cells and inhibits it in non-aggressive cells through STAT6 phospho-regulation. Sci Rep. 2019;9(1):7782.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Iwakuma T, Harimaya K, et al. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing’s sarcoma and primitive neuroectodermal tumor cells. J Clin Invest. 1997;99(2):239–247.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yuan Y, Jiang L, et al. Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: involvement of PARK2-dependent mitophagy. Autophagy. 2014;10(10):1801–1813.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ji M, Wang Q, et al. Circular RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in ovarian cancer via miR-1270 suppression. Mol Ther Nucleic Acids. 2019;18:24–33.
   PubMedGoogle Scholar
• Li J-H, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–97.
   PubMed Web of Science ®Google Scholar
• Betel D, Wilson M, Gabow A, et al. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36(Database):D149–153.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.
   PubMed Web of Science ®Google Scholar
• Kertesz M, Iovino N, Unnerstall U, et al. The role of site accessibility in microRNA target recognition. Nat Genet. 2007;39(10):1278–1284.
   PubMed Web of Science ®Google Scholar
• Li N, Zhang R. Silencing of p53 reduces cell migration in human Tenon’s fibroblasts induced by TGF-β. Int Ophthalmol. 2020;40(6):1509–1516.
   PubMed Web of Science ®Google Scholar
• Gutterman Y, Chauser-Volfson E. The content of secondary phenol metabolites in pruned leaves of Aloe arborescens, a comparison between two methods: leaf exudates and leaf water extract. J Nat Med. 2008;62(4):430–435.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang L, Fan K, et al. Aloin promotes A549 cell apoptosis via the reactive oxygen speciesmitogen activated protein kinase signaling pathway and p53 phosphorylation. Mol Med Rep. 2017;16(5):5759–5768.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang L, Fan K, et al. Aloin promotes A549 cell apoptosis via the reactive oxygen species‑mitogen activated protein kinase signaling pathway and p53 phosphorylation. Mol Med Rep. 2017;16(5):5759–5768.
   PubMed Web of Science ®Google Scholar
• Yan L, Yang S, Yue CX, et al. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Environ Toxicol. 2020;35(9):1015–1028.
   PubMed Web of Science ®Google Scholar
• Luo Z, Mao X, Cui W. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma. Med Oncol. 2019;36(10):86.
   PubMed Web of Science ®Google Scholar
• Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151.
   PubMed Web of Science ®Google Scholar
• Shi L, Yan P, Liang Y, et al. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma. Cell Death Dis. 2017;8(11):e3171.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Lu G, and Luo Z, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun. 2018;497(2) ;S0006291X18303504.
   Web of Science ®Google Scholar
• Xu K, Liu X, Mao X, et al. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem. 2015;35(2):499–515.
   PubMedGoogle Scholar
• Chan SH, Huang WC, Chang JW, et al. MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. Oncogene. 2014;33(36):4496–4507.
   PubMed Web of Science ®Google Scholar
• Ying W, Zheng X, Zhang Z, et al. MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. Plos One. 2012;7(10):e41693.
   PubMed Web of Science ®Google Scholar
• Dong J, Teng F, Guo W, et al. lncRNA SNHG8 promotes the tumorigenesis and metastasis by sponging mir-149-5p and predicts tumor recurrence in hepatocellular carcinoma. Cell Physiol Biochem. 2018;51(5):2262–2274.
   PubMedGoogle Scholar
• Taube ET, Denkert C, Sehouli J, et al. Wilms tumor protein 1 (WT1) — not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma. Gynecol Oncol. 2016;140(3):494–502.
   PubMed Web of Science ®Google Scholar
• Wang N, Tan H, Chan Y, et al. Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine salvia chinensis benth and its active ingredient protocatechualdehyde. Oncotarget. 2017;8(62):105848–105859.
   PubMedGoogle Scholar
• Cheng Y, Qiu L, He GL, et al. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway. Eur Rev Med Pharmacol Sci. 2019;23:8823–8832.
   PubMed Web of Science ®Google Scholar
• Wang Z, Tang T, Wang S, et al. Aloin inhibits the proliferation and migration of gastric cancer cells by regulating NOX2-ROS-mediated pro-survival signal pathways. Drug Des Devel Ther. 2020;14:145–155.
   PubMed Web of Science ®Google Scholar
• Li P, Ren K, Liang YY, et al. Aloin promotes cell apoptosis by targeting HMGB1-TLR4-ERK axis in human melanoma cells. Excli J. 2020;19:641–651.
   PubMed Web of Science ®Google Scholar